Mencevax ACWY Injection 50mcg

About Mencevax ACWY Injection 50mcg

Mencevax ACWY Injection Uses

• Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W135, and Y
• Vaccination for travelers heading to meningitis belt regions of sub Saharan Africa
• Mandatory vaccination requirement for Hajj and Umrah pilgrims applying for a Saudi Arabia visa
• Protection for people with asplenia or complement deficiencies who face higher infection risk
• Use in outbreak control and prophylaxis for close contacts of a confirmed case

Mencevax ACWY Injection Benefits

• Produces protective antibody levels within one to two weeks after a single dose
• Covers four major disease causing serogroups in one vaccination
• Meets the Saudi Ministry of Health requirement for Hajj and Umrah visa applications
• Lowers the risk of severe complications such as meningitis, sepsis, and death

What Experts Say

Neisseria meningitidis can cause sudden, severe illness such as meningitis and meningococcemia, a bloodstream infection. Symptoms can worsen within hours, and even with prompt treatment the disease carries real risk of death or lasting disability. Serogroups A, C, W135, and Y account for a large share of invasive cases worldwide.

A polysaccharide vaccine exposes the immune system to the bacterial capsule's outer sugar coating, prompting antibody production against that serogroup. This response is usually shorter lived than with newer conjugate vaccines and weaker in children under two years, so such vaccines suit older children, adolescents, and adults better.

Because protection wanes over time, people with ongoing exposure risk or certain immune conditions should discuss revaccination timing with a qualified healthcare professional. Polysaccharide ACWY vaccines still serve an important role in specific situations, even though conjugate vaccines are now preferred for routine immunization in many countries.

Drug Class

• Bacterial Polysaccharide Vaccine
• Meningococcal Vaccine (Serogroups A, C, W135, Y)

Mencevax ACWY Injection 50mcg formula

• Meningococcal Polysaccharide Vaccine (Groups A, C, W135, and Y)

Available forms

• Injection

How to use Mencevax ACWY Injection 50mcg?

• Administered only by a qualified doctor or trained healthcare professional in a clinic or hospital setting
• Given as a single 0.5 mL dose by subcutaneous injection, usually into the upper arm
• Approved for use in adults and children above 2 years of age
• Not intended for intravenous administration under any circumstance
• A booster dose may be advised every 3 to 5 years for individuals with continued exposure risk

Drug Interactions

• Immunosuppressive Medicines: Corticosteroids, chemotherapy agents, or biologic immunosuppressants can reduce the antibody response to this vaccine
• Other Vaccines: Can generally be given at the same visit as other vaccines but at separate injection sites
• Immunoglobulins Or Blood Products: Recent immunoglobulin administration or blood transfusion may affect vaccine timing
• Radiation Therapy: Ongoing radiation treatment can lower immune response

Risks and warnings

• Allergic Reaction Risk: Should not be given to anyone with a known severe allergic reaction to a previous dose
• Acute Illness: Vaccination should be postponed in people with moderate to severe acute febrile illness
• Limited Protection In Young Children: Immune response is weaker and shorter lasting in children under 2 years
• Not A Treatment: This vaccine does not treat an existing meningococcal infection
• Immunocompromised Individuals: A weakened immune system may reduce antibody response

Mencevax ACWY Injection Side Effects

• Pain, redness, or swelling at the injection site
• Mild fever
• Headache
• Fatigue or general malaise
• Irritability, especially in children
• Nausea
• Muscle or joint aches
• Dizziness

Storage Conditions

• Store in a refrigerator between 2°C and 8°C at all times
• Do not freeze, since freezing destroys the vaccine
• Keep the vial in its original carton to protect it from light
• Reconstitute the vaccine immediately before use
• Keep out of reach of children